These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 17979497)

  • 41. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
    Oikawa T; Freeman M; Lo W; Vaughan DE; Fogo A
    Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X; Li C; Li X; Cai L
    Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts.
    Liu RM; Choi J; Wu JH; Gaston Pravia KA; Lewis KM; Brand JD; Mochel NS; Krzywanski DM; Lambeth JD; Hagood JS; Forman HJ; Thannickal VJ; Postlethwait EM
    J Biol Chem; 2010 May; 285(21):16239-47. PubMed ID: 20228065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system.
    Tomooka S; Border WA; Marshall BC; Noble NA
    Kidney Int; 1992 Dec; 42(6):1462-9. PubMed ID: 1474781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Protective effects of Hirsutella sinensis on renal interstitial fibrosis: experiment with rat model of chronic aristolochic acid nephropathy].
    Zhu YF; Chen YP; Rui HL; Dong HR; Hu Z
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2667-71. PubMed ID: 18167239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.
    Berg DT; Myers LJ; Richardson MA; Sandusky G; Grinnell BW
    J Biol Chem; 2005 Apr; 280(15):14943-7. PubMed ID: 15716278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasminogen activator inhibitor-1 in aging.
    Yamamoto K; Takeshita K; Saito H
    Semin Thromb Hemost; 2014 Sep; 40(6):652-9. PubMed ID: 25122500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-β1/Smad3/ plasminogen activator inhibitor-1 signaling pathway.
    Wang J; Fang C; Wang S; Fang F; Chu X; Liu N; Lu C; Wang S; Li W
    J Tradit Chin Med; 2020 Apr; 40(2):236-244. PubMed ID: 32242389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracellular matrix degradation by cultured mesangial cells: mediators and modulators.
    Baricos WH; Reed JC; Cortez SL
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1018-22. PubMed ID: 14530509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
    Hao GH; Niu XL; Gao DF; Wei J; Wang NP
    Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver.
    Knittel T; Fellmer P; Ramadori G
    Gastroenterology; 1996 Sep; 111(3):745-54. PubMed ID: 8780581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of plasminogen activator inhibitor-1 attenuates against intestinal fibrosis in mice.
    Imai J; Yahata T; Ichikawa H; Ibrahim AA; Yazawa M; Sumiyoshi H; Inagaki Y; Matsushima M; Suzuki T; Mine T; Ando K; Miyata T; Hozumi K
    Intest Res; 2020 Apr; 18(2):219-228. PubMed ID: 32050315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
    Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
    Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes.
    Macfelda K; Weiss TW; Kaun C; Breuss JM; Zorn G; Oberndorfer U; Voegele-Kadletz M; Huber-Beckmann R; Ullrich R; Binder BR; Losert UM; Maurer G; Pacher R; Huber K; Wojta J
    J Mol Cell Cardiol; 2002 Dec; 34(12):1681-91. PubMed ID: 12505065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
    Nicholas SB; Aguiniga E; Ren Y; Kim J; Wong J; Govindarajan N; Noda M; Wang W; Kawano Y; Collins A; Hsueh WA
    Kidney Int; 2005 Apr; 67(4):1297-307. PubMed ID: 15780082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide attenuates plasminogen activator inhibitor-1 expression in human pleural mesothelial cells.
    Chung CL; Sheu JR; Chen WL; Chou YC; Hsiao CJ; Hsiao SH; Hsu MJ; Cheng YW; Hsiao G
    Am J Respir Cell Mol Biol; 2012 Apr; 46(4):437-45. PubMed ID: 22033265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
    Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
    Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1.
    Chuang-Tsai S; Sisson TH; Hattori N; Tsai CG; Subbotina NM; Hanson KE; Simon RH
    Am J Pathol; 2003 Aug; 163(2):445-52. PubMed ID: 12875966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
    Albo D; Berger DH; Vogel J; Tuszynski GP
    J Gastrointest Surg; 1999; 3(4):411-7. PubMed ID: 10482694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynasore, a dynamin inhibitor, induces PAI-1 expression in MeT-5A human pleural mesothelial cells.
    Chung CL; Sheu JR; Liu HE; Chang SC; Chou YC; Chen WL; Chou DS; Hsiao G
    Am J Respir Cell Mol Biol; 2009 Jun; 40(6):692-700. PubMed ID: 18978303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.